Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

EU-PEARL hopes to transform standard clinical trials into collaborative multi-compound research platforms focused on patients.

These results contribute to improving the treatment of ADHD and insomnia, as well as to better understanding the interactions between these two complex disorders.

El Dr. Josep Antoni Ramos Quiroga, la Dra. Núria Gómez Barros, la Dra. Sala Guila, el Dr. Francisco Collazos i el Dr. Marc Ferrer, del Servei de Salut Mental de Vall d’Hebron, han aparegut al llarg de les més de 15 hores de programa.

This work is the base to develop an integrate research platform focus on this pathology.

The study, led by Anna Beneria, specialist physician of the Mental Health Service, concludes that these methodologies have shortcomings and proposes the implementation of improvements in the follow-up of young people.

The EVOLUTION trial is currently in phase IIb and it will evaluate the effect of the Vafidemstat drug on cognitive effects and the negative effects deriving from the illness.

The results of this study led by the Psychiatry Service in Vall d'Hebron are essential to understand the experience of families and patients and assess the need for specific psychological interventions.